ImageneBio Inc (IMA) investor relations documents from the company's IR site: 11 press releases. Read in-app with summaries. First-party data.
| Published | Type | Document |
|---|---|---|
| 2026-08-17 | Press release | PDF Version |
| 2026-08-17 | Press release | ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-08-05 | Press release | PDF Version |
| 2026-08-05 | Press release | ImageneBio Reports Second Quarter 2026 Financial Results |
| 2026-07-07 | Press release | PDF Version |
| 2026-07-07 | Press release | ImageneBio Appoints Matt Robbins as General Counsel |
| 2026-05-27 | Press release | ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York |
| 2026-05-07 | Press release | ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update |
| 2026-04-13 | Press release | ImageneBio Announces $30 Million Private Placement |
| 2026-03-17 | Press release | ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-02-10 | Press release | ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer |
IMA overview · IMA earnings · IMA financials · IMA KPIs · IMA ownership · IMA peers · IMA filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.